These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3950582)

  • 101. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.
    Julander JG; Trent DW; Monath TP
    Vaccine; 2011 Aug; 29(35):6008-16. PubMed ID: 21718741
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.
    Avirutnan P; Hauhart RE; Somnuke P; Blom AM; Diamond MS; Atkinson JP
    J Immunol; 2011 Jul; 187(1):424-33. PubMed ID: 21642539
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.
    Youn S; Cho H; Fremont DH; Diamond MS
    J Virol; 2010 Sep; 84(18):9516-32. PubMed ID: 20592095
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
    Shrestha B; Brien JD; Sukupolvi-Petty S; Austin SK; Edeling MA; Kim T; O'Brien KM; Nelson CA; Johnson S; Fremont DH; Diamond MS
    PLoS Pathog; 2010 Apr; 6(4):e1000823. PubMed ID: 20369024
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.
    Krishna VD; Rangappa M; Satchidanandam V
    J Virol; 2009 May; 83(10):4766-77. PubMed ID: 19264772
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
    Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
    J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Flavivirus nonstructural protein NS1: complementary surprises.
    Schlesinger JJ
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18879-80. PubMed ID: 17146046
    [No Abstract]   [Full Text] [Related]  

  • 108. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.
    Chung KM; Nybakken GE; Thompson BS; Engle MJ; Marri A; Fremont DH; Diamond MS
    J Virol; 2006 Feb; 80(3):1340-51. PubMed ID: 16415011
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Complement activation is required for induction of a protective antibody response against West Nile virus infection.
    Mehlhop E; Whitby K; Oliphant T; Marri A; Engle M; Diamond MS
    J Virol; 2005 Jun; 79(12):7466-77. PubMed ID: 15919902
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
    Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
    J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.
    Timofeev AV; Butenko VM; Stephenson JR
    Virus Genes; 2004 Jan; 28(1):85-97. PubMed ID: 14739654
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Development of a recombinant vaccine against Japanese encephalitis.
    Kaur R; Vrati S
    J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.
    Gritsun TS; Frolova TV; Zhankov AI; Armesto M; Turner SL; Frolova MP; Pogodina VV; Lashkevich VA; Gould EA
    J Virol; 2003 Jan; 77(1):25-36. PubMed ID: 12477807
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.
    Verrier F; Nádas A; Gorny MK; Zolla-Pazner S
    J Virol; 2001 Oct; 75(19):9177-86. PubMed ID: 11533181
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The antiviral activity of antibodies in vitro and in vivo.
    Parren PW; Burton DR
    Adv Immunol; 2001; 77():195-262. PubMed ID: 11293117
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
    Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
    J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons.
    Gorrell MD; Lemm JA; Rice CM; Griffin DE
    J Virol; 1997 May; 71(5):3415-9. PubMed ID: 9094611
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model.
    Kreil TR; Eibl MM
    J Virol; 1997 Apr; 71(4):2921-7. PubMed ID: 9060650
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation.
    Muylaert IR; Galler R; Rice CM
    J Virol; 1997 Jan; 71(1):291-8. PubMed ID: 8985349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.